Relationship between ABO blood group and von Willebrand factor levels: From biology to clinical implications

Thrombosis Journal

Volumn 5, Issue , 2007, Pages

  Franchini, Massimo ^a   Capra, Franco ^b   Targher, Giovanni ^b   Montagnana, Martina ^b   Lippi, Giuseppe ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; BLOOD GROUP H ANTIGEN; BLOOD GROUP O ANTIGEN; GLYCOSYLTRANSFERASE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ALLELE; ANTIGEN EXPRESSION; ARTERY THROMBOSIS; BLOOD GROUP ABO SYSTEM; BLOOD GROUP O; DEEP VEIN THROMBOSIS; ETHNIC DIFFERENCE; GENETIC RISK; HEMOSTASIS; HUMAN; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VENOUS THROMBOEMBOLISM;

EID: 35648950400     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-5-14     Document Type: Review

References (53)

1. Ruggeri ZM Zimmerman TS The complex multimeric composition of factor VIII/vWF Blood 1981, 57:1140-1143. 6784794
2. Sadler JE von Willebrand factor Ann Rev Biochem 1998, 67:395-424. 10.1146/annurev.biochem.67.1.395 9759493
3. Ruggeri ZM Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation Best Pract ResClinical Haematol 2001, 14:257-259. 10.1053/beha.2001.0133
4. Vlot AJ Koppelman SJ Bouma BN Sixma JJ Factor VIII and von Willebrand Factor Thromb Haemost 1998, 79:456-465. 9531024
5. Ruggeri ZM Zimmerman TS von Willebrand factor and von Willebrand disease Blood 1987, 70:895-904. 3307951
6. Whincup PH Danesh J Walker M Lennon L Thomson A Appleby P Rumley A Lowe GD von Willebrand factor and coronary heart disease: Prospective study and meta-analysis Eur Heart J 2002, 23:1764-1770. 10.1053/euhj.2001.3237 12419296
7. Franchini M Lippi G Von Willebrand factor and thrombosis Ann Hematol 2006, 85:415-423. 10.1007/s00277-006-0085-5 16568319
8. O'Donnell JS Lasffan MA The relationship between ABO histo-blood group, factor VIII and von Willebrand factor Transfus Med 2001, 11:343-351. 10.1046/j.1365-3148.2001.00315.x 11532189
9. Jenkins PV O'Donnell JS ABO blood group determines plasma von Willebrand factor levels: A biologic function after all? Transfusion 2006, 46:1836-1844. 10.1111/j.1537-2995.2006.00975.x 17002642
10. Lowe J The blood group-specific human glycosyltransferases Baillieres Clin Haematol 1993, 6:465-490. 10.1016/S0950-3536(05)80155-6 8043935
11. Gastineau DA Moore SB How important are ABO-related variations in coagulation factor levels? Transfusion 2001, 41:4-5. 10.1046/ j.1537-2995.2001.41010004.x 11161237
12. McCallum CJ Peake IR Newcombe RG Bloom AL Factor VIII levels and blood group antigens Thromb Haemost 1983, 50:757. 6417823
13. Mohanty D Ghosh K Marwaha N Kaur S Chauhan AP Das KC Major blood group antigens - a determinant of factor VIII levels in blood? Thromb Haemost 1984, 51:414. 6437009
14. Orstavik KH Magnus P Reisner H Berg K Graham JB Nance W Factor VIII and factor IX in a twin population: Evidence for a major effect of ABO locus on factor VIII level Am J Hum Genet 1985, 37:89-101. 1684532 3919575
15. Gill JC Endres-Brooks J Bauer PJ Marks WJ Jr Montgomery RR The effect of ABO blood group on the diagnosis of von Willebrand disease Blood 1987, 69:1691-1695. 3495304
16. Nitu-Whalley IC Lee CA Griffioen A Jenkins PV Pasi KJ Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history Br J Haematol 2000, 108:259-264. 10.1046/ j.1365-2141.2000.01830.x 10691852
17. Moeller A Weippert-Kretschmer M Prinz H Kretschmer V Influence of ABO blood groups on primary hemostasis Transfusion 2001, 41:56-60. 10.1046/ j.1537-2995.2001.41010056.x 11161246
18. Miller CH Haff E Platt SJ Rawlins P Drews CD Dilley AB Evatt B Measurement of von Willebrand factor activity: Relative effects of ABO blood type and race J Thromb Haemost 2003, 1:2191-2197. 10.1046/ j.1538-7836.2003.00367.x 14521604
19. Shima M Fujimura Y Nishiyama T Tsujiuchi T Narita N Matsui T Titani K Katayama M Yamamoto F Yoshioka A ABO blood group genotype and plasma von Willebrand factor in normal individuals Vox Sang 1995, 68:236-240. 7660643
20. Souto JC Almasy L Muniz-Diaz E Soria JM Borrell M Bayen L Mateo J Madoz P Stone W Blangero J Fontcuberta J Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time Arterioscler Thromb Vasc Biol 2000, 20:2024-2028. 10938027
21. Sousa CM Anicchino-Bizzacchi JM Locatelli MF Catsro V Barjas-Castro L The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor Haematologica 2007, 92:236-239. 17296574
22. O'Donnell J Boulton FE Manning RA Laffan MA Genotype at the secretor blood group locus is a determinant of plasma von Willebrand factor level Br J Haematol 2002, 116:350-356. 10.1046/j.1365-2141.2002.03270.x 11841438
23. Matsui T Titani K Mizuochi T Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures J Biol Chem 1992, 267:8723-8731. 1577715
24. Mohlke KL Purkayastha AA Westrick RJ Smith PL Petryniak B Lowe JB Ginsburg D Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase Cell 1999, 96:111-120. 10.1016/S0092-8674(00)80964-2 9989502
25. O'Donnell J Boulton FE Manning RA Laffan MA Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels Arterioscler Thromb Vasc Biol 2002, 22:335-341. 10.1161/hq0202.103997 11834538
26. Morelli VM de Visser MC van Tilburg NH Vos HL Eikenboom JC Rosendaal FR Bertina RM ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens Thromb Haemost 2007, 97:534-541. 17393014
27. Sarode R Goldstein J Sussman II Nagel RL Tsai HM Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor Br J Haematol 2000, 109:857-64. 10.1046/j.1365-2141.2000.02113.x 10929042
28. Lenting PJ van Schooten CJM Denis CV Clearance mechanisms of von Willebrand factor and factor VIII J Thromb Haemost 2007, 5:1353-1360. 10.1111/j.1538-7836.2007.02572.x 17425686
29. Brown SA Eldridge A Collins PW Bowen DJ Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process? J Thromb Haemost 2003, 1:1714-1717. 10.1046/j.1538-7836.2003.00359.x 12911582
30. Ellies LG Ditto D Levy GG Wahrenbrock M Ginsburg D Varki A Le DT Marth JD Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands Proc Natl Acad Sci USA 2002, 99:10042-10047. 126621 12097641 10.1073/pnas.142005099
31. Sodetz JM Pizzo SV McKee PA Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein J Biol Chem 1977, 252:5538-5546. 301877
32. Nossent AY van Marion V van Tilburg NH Rosendaal FR Bertina RM van Mourik JA Eikenboom HC von Willebrand factor and its propeptide: The influence of secretion and clearance on protein levels and the risk of venous thrombosis J Thromb Haemost 2006, 4:2256-2262. 10.1111/ j.1538-7836.2006.02273.x 16856978
33. Vlot AJ Mauser-Bunschoten EP Zarkova AG Haan E Kruitwagen CL Sixma JJ van den Berg HM The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A Thromb Haemost 2000, 83:65-69. 10669157
34. O'Donnell JS McKinnon TA Crawley JT Lane DA Laffan MA Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis Blood 2005, 106:1988-1991. 10.1182/blood-2005-02-0792 15886321
35. Bowen DJ An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13 J Thromb Haemost 2003, 1:33-40. 10.1046/j.1538-7836.2003.00007.x 12871537
36. Federici AB Elder JH De Marco L Ruggeri ZM Zimmerman TS Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation J Clin Invest 1984, 74:2049-2055. 425394 6239876
37. Horwich L Evans D McConnell R Donohoe W ABO blood groups in gastric bleeding Gut 1966, 7:680-685. 1552641 5297336 10.1136/gut.7.6.680
38. Evans D Horwich L McConnell R Bullen M Influence of the ABO blood groups and secretor status on bleeding and on perforation of duodenal ulcer Gut 1968, 9:319-322. 1552588 5661969 10.1136/gut.9.3.319
39. Ionescu DA Ghitescu M Marcu I Xenakis A Erythrocyte rheology in acute cerebral thrombosis. Effects of ABO blood groups Blut 1979, 39:351-357. 10.1007/BF01014198 508955
40. Meade TW Cooper JA Stirling Y Howarth DJ Ruddock V Miller GJ Factor VIII, ABO blood group and the incidence of ischaemic heart disease Br J Haematol 1994, 88:601-607. 7819072
41. Whincup PH Cook DG Phillips AN Shaper AG ABO blood group and ischaemic heart disease in British men BMJ 1990, 300:1679-1682. 1663328 2390546
42. Garrison RJ Havlik RJ Harris RB Feinleib M Kannel WB Padgett SJ ABO blood group and cardiovacular disease: The Framingham study Atheroslerosis 1976, 25:311-318. 10.1016/0021-9150(76)90036-8
43. Jager A van Hinsbergh VW Kostense PJ Emeis JJ Yudkin JS Nijpels G Dekker JM Heine RJ Bouter LM Stehouwer CD von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: The Hoorn Study Arterioscler Thromb Vasc Biol 1999, 19:3071-3078. 10591689
44. Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP Worcester J Venous thromboembolic disease and ABO blood type. A cooperative study Lancet 1969, 1:539-542. 10.1016/S0140-6736(69)91955-2 4179835
45. Wautrecht JC Galle C Motte S Dereume JP Dramaix M The role of ABO blood groups in the incidence of deep vein thrombosis Thromb Haemost 1998, 79:668-669. 9531060
46. Larsen TB Johnsen SP Gislum M Moller CA Larsen H Sorensen HT ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study J Thromb Haemost 2005, 3:300-304. 10.1111/j.1538-7836.2005.01195.x 15670036
47. Schleef M Strobel E Dick A Frank J Schramm W Spannagl M Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals Br J Haematol 2004, 128:100-107. 10.1111/j.1365-2141.2004.05249.x
48. Morelli VM De Visser MC Vos HL Bertina RM Rosendaal FR ABO blood group genotypes and the risk of venous thrombosis: Effect of factor V Leiden Thromb Haemost 2005, 3:183-185. 10.1111/j.1538-7836.2004.01071.x
49. Koster T Blann AD Briet E Vandenbroucke JP Rosendaal FR Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis Lancet 1995, 345:152-155. 10.1016/ S0140-6736(95)90166-3 7823669
50. Folsom AR Wu KK Rosamond WD Sharrett AR Chambless LE Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study Circulation 1997, 96:1102-1108. 9286936
51. Vischer UM Von Willebrand factor, endothelial dysfunction, and cardiovascular disease J Thromb Haemost 2006, 4:1186-1193. 10.1111/ j.1538-7836.2006.01949.x 16706957
52. Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism Thromb Haemost 2005, 93:468-474. 15735796
53. Ohira T Cushman M Tsai MY Zhang Y Heckbert SR Zakai NA Rosamond WD Folsom AR ABO blood group, other risk factors and incidence of venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE) J Thromb Haemost 2007, 5:1455-1461. 10.1111/ j.1538-7836.2007.02579.x 17425663